Others Products Targets
- STAT (10)
- JAK (10)
- Adenosine A2B Receptor (7)
- Adenosine A2A Receptor (11)
- NFKB and IKB (30)
- Toll-like Receptor (11)
- TGF-β Receptor (9)
- STING-Dependent Signaling (1)
- NFAT (5)
- Lipoxygenase (8)
- Leukotriene and Related Receptor (13)
- Integrin Receptor (15)
- Inflammasomes (1)
- Others (16)
- Glucocorticoid Receptor (9)
- Cytokine Receptor (4)
- Cyclooxygenase (24)
- Complement (2)
- IRAK (1)
- Antiviral (36)
- Histamine H4 Receptor (12)
- Histamine H3 Receptor (22)
- Histamine H2 Receptor (10)
- Histamine H1 Receptor (17)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- Adenosine A3 Receptor (8)
- Adenosine A1 Receptor (12)
- Janus N-terminal Kinase (12)
- AP-1 (2)
- Purinergic (P2Y) Receptor (31)
- Purinergic (P2X) Receptor (32)
- Prostanoid Receptor (24)
- Cytokine (15)
- Platelet-Activating Factor (PAF) Receptor (5)
Products for Others - Page 11
- Cat.No. Product Name Information/Activity
-
BCC7694
RGDS peptide
Arg-Gly-Asp-Ser is an integrin binding sequence that inhibits integrin receptor function, decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, iNOS and MMP-9.
-
BCC6216
TC-I 15
916734-43-5
-
BCC6080
TCS 2314
TCS 2314 (compound 3) is orally active and selective very late antigen-4 (VLA-4, α4β1, CD49d/CD29) antagonist with an IC50 of 4.4 nM.
-
BCC6332
Leukadherin 1
Leukadherin-1 is a specific agonist of complement receptor 3 (CR3) and the leukocyte surface αMβ2 integrin CD11b/CD18.
-
BCC6229
LDV FITC
1207610-07-8
-
BCC7894
RWJ 50271
RWJ 50271 is an selective inhibitor of lymphocyte function-associated antigen-1/intercellular adhesion molecule-1(LFA-1/ICAM-1) interaction with an IC50 of 5.0 μM (HL60 cells).
-
BCC7576
BAY-u 9773
Dual CysLT<sub>1</sub> and CysLT<sub>2</sub> antagonist
-
BCC7244
Cinalukast
128312-51-6
-
BCC7310
FPL 55712
40785-97-5
-
BCC7334
MK 571
MRP1 inhibitor; also CysLT<sub>1</sub> (LTD<sub>4</sub>) inverse agonist
